# TrophoSYS

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/trophosys

- Industry: Biotechnology
- Headquarters: Jena, Germany
- Website: www.trophosys.com
- Latest round: Series A (Jan 17, 2022)
- Investors on record: 3

## About

Based in Jena, Germany, and founded in 2016 by Stephan König, TrophoSYS GmbH, a.k.a. TrophoSYS is a biotechnology company that focuses on advancing technologies that optimize breeding processes while adhering to environmental and ethical considerations. In January 2022, TrophoSYS GmbH raised an undisclosed amount of a Series A funding led by Bm-t, with participation from Treuenburg GmbH and Sparkasse Jena-Saale-Holzland.

TrophoSYS focuses on two key areas: separating live and dead cells in ejaculates to improve breeding results, and separating X and Y chromosome-containing sperm for targeted livestock rearing. These technologies enable efficient and ethical livestock management, reducing the environmental impact and enhancing animal welfare.

## Funding rounds

- Series A, Jan 17, 2022 — Bm-t, Treuenburg GmbH, Sparkasse Jena-Saale-Holzland
- Seed, Dec 11, 2018 — Bm-t, Sparkasse Jena-Saale-Holzland

## Investors

- Bm-t (https://capitalatlas.ai/funds/bm-t) — Seed, Series A
- Sparkasse Jena-Saale-Holzland — Seed, Series A
- Treuenburg GmbH (https://capitalatlas.ai/funds/treuenburg-gmbh) — Series A